| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/25/2014 | US8895533 Starch derivative mixtures |
| 11/25/2014 | US8895532 Use of hyaluronic acid for the preparation of compositions intended for improving in particular the protective function of the skin, the eye and the mucous membranes |
| 11/25/2014 | US8895531 2′-fluoronucleoside phosphonates as antiviral agents |
| 11/25/2014 | US8895530 Method of reducing intraocular pressure in humans |
| 11/25/2014 | US8895529 Antisense modulation of fibroblast growth factor receptor 4 expression |
| 11/25/2014 | US8895527 Treatment of transcription factor E3 (TFE3) and insulin receptor substrate 2(IRS2) related diseases by inhibition of natural antisense transcript to TFE3 |
| 11/25/2014 | US8895524 Viral microRNA |
| 11/25/2014 | US8895522 Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease |
| 11/25/2014 | US8895521 Methods and compositions for the treatment of uveitis |
| 11/25/2014 | US8895520 Method for treating a human patent suffering from Myeloid Neoplasias using 5-aminoimidazole-4-carboxamide |
| 11/25/2014 | US8895519 Aminoglycosides and uses thereof in treating genetic disorders |
| 11/25/2014 | US8895518 Cooperative conveyance of basic active principles by amphiphilic acid molecules |
| 11/25/2014 | US8895517 Pesticidal composition and its use |
| 11/25/2014 | US8895516 Modified saccharides, conjugates thereof, and their manufacture |
| 11/25/2014 | US8895511 Use of sarcoplasmic CA2+-ATPase type 2 protein for diagnosing and treating learning or mental disorders |
| 11/25/2014 | US8895510 Pan-selectin inhibitor with enhanced pharmacokinetic activity |
| 11/25/2014 | US8895509 MIR-200 family induces mesenchymal-to-epithelial transition (MET) in ovarian cancer cells |
| 11/25/2014 | US8895501 Eye-drop vaccine containing copolymer 1 for therapeutic immunization |
| 11/25/2014 | US8895306 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 11/25/2014 | US8895303 Method of cell culture and method of treatment comprising a vEPO protein variant |
| 11/25/2014 | US8895245 Inhibitors of human EZH2 and methods of use thereof |
| 11/25/2014 | US8895242 Single molecule nucleic acid nanoparticles |
| 11/25/2014 | US8895087 Composition to enhance the bioavailability of curcumin |
| 11/25/2014 | US8895085 Agglomerated oil impregnated psyllium husk |
| 11/25/2014 | US8895084 Oral care composition containing extract of unoxidized Camellia |
| 11/25/2014 | US8895081 Formulation for treatment of dry mouth and mouth sores |
| 11/25/2014 | US8895079 Combinations of botanical extracts for promoting cardiovascular health |
| 11/25/2014 | US8895078 Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts |
| 11/25/2014 | US8895077 Methods for preventing or treating infectious diseases caused by extracellular microorganisms, including antimicrobial-resistant strains thereof, using gallium compounds |
| 11/25/2014 | US8895076 Liquid composition of cisplatin coordination compound |
| 11/25/2014 | US8895074 Therapeutic application of parenteral krill oil |
| 11/25/2014 | US8895070 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
| 11/25/2014 | US8895069 Drug delivery system using hyaluronic acid-peptide conjugate micelle |
| 11/25/2014 | US8895066 Bilayer composition for the sustained release of acetaminophen and tramadol |
| 11/25/2014 | US8895065 Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof |
| 11/25/2014 | US8895064 Controlled release and taste masking oral pharmaceutical composition |
| 11/25/2014 | US8895062 Surface-layer protein coated microspheres and uses thereof |
| 11/25/2014 | US8895061 Compositions comprising carisoprodol and methods of use thereof |
| 11/25/2014 | US8895059 Reduction of cross-linking gelatin in gelatin capsules |
| 11/25/2014 | US8895058 Low dose topiramate/phentermine composition and methods of use thereof |
| 11/25/2014 | US8895057 Escalating dosing regimen for effecting weight loss and treating obesity |
| 11/25/2014 | US8895056 Regional delivery of therapeutic agents for the treatment of vascular diseases |
| 11/25/2014 | US8895055 Telodendrimer nanodiscs without apolipoprotein |
| 11/25/2014 | US8895054 Methods for joint lubrication and cartilage wear prevention making use of glycerophospholipids |
| 11/25/2014 | US8895053 Testosterone formulations |
| 11/25/2014 | US8895052 Biodegradable compositions having pressure sensitive adhesive properties |
| 11/25/2014 | US8895049 Extended release biodegradable ocular implants |
| 11/25/2014 | US8895047 Combined fibrinolytic and antimicrobial catheter and uses thereof |
| 11/25/2014 | US8895041 Compositions for delivering perfume to the skin |
| 11/25/2014 | US8895039 Cosmetic preparations containing hydrocarbons |
| 11/25/2014 | US8895036 Topical compositions to treat circulatory disorders |
| 11/25/2014 | US8895034 Collagen production compound |
| 11/25/2014 | US8895033 Sustained release formulations using non-aqueous carriers |
| 11/25/2014 | US8895031 Reagents and methods for cancer treatment and prevention |
| 11/25/2014 | US8895027 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene |
| 11/25/2014 | US8895019 Biofilm treatment |
| 11/25/2014 | US8895011 Insulin-resistance-improving drug |
| 11/25/2014 | US8895004 Method for the treatment of amyloidoses |
| 11/25/2014 | US8895001 Use of ErbB3 inhibitors in the treatment of triple negative and basal-like breast cancers |
| 11/25/2014 | US8894999 Use of DR6 and p75 antagonists to promote survival of cells of the nervous system |
| 11/25/2014 | US8894996 Immunoadjuvant composition and use thereof |
| 11/25/2014 | US8894993 Mitochondria-targeted antioxidants |
| 11/25/2014 | US8894992 Compositions and soft tissue replacement methods |
| 11/25/2014 | US8894990 Method for treating psoriatic arthritis by administering an anti-IL-12 antibody |
| 11/25/2014 | US8894988 Tamper resistant dosage forms |
| 11/25/2014 | US8894987 Tamper resistant dosage forms |
| 11/25/2014 | US8894986 Wound healing compositions including cyanoacrylate monomers and phenytoin |
| 11/25/2014 | US8894985 Nitric oxide-releasing polymers |
| 11/25/2014 | US8894979 Composition containing at least one C7 sugar for alopecia treatment, cosmetic treatment of hair and nails, and care of hair, eyelashes, or nails |
| 11/25/2014 | US8894978 System and method of complimentary day/night children's skin cream compositions |
| 11/25/2014 | US8894977 Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound |
| 11/25/2014 | US8894974 Radiopharmaceuticals for diagnosis and therapy |
| 11/25/2014 | US8894973 Method and system for differential diagnosis of chronic schizophrenia and chronic alcoholism |
| 11/25/2014 | US8894970 Arginase inhibitors and methods of use thereof |
| 11/25/2014 | US8894630 Device, system, and method for targeted delivery of anti-inflammatory medicaments to a mammalian subject |
| 11/25/2014 | US8894621 Self-destructing transdermal therapeutic system having improved functionality and efficacy |
| 11/20/2014 | US20140343491 Macrolide particulates, methods for preparation, and medical devices associated therewith |
| 11/20/2014 | US20140343480 Systems, methods, and compositions for cross-linking |
| 11/20/2014 | US20140343479 Advanced methods and systems for treating cell proliferation disorders |
| 11/20/2014 | US20140343347 Methods and related compositions for the treatment of cancer |
| 11/20/2014 | US20140343288 Sublingual fentanyl spray |
| 11/20/2014 | US20140343167 Use of citral for treating focal segmental glomerulosclerosis |
| 11/20/2014 | US20140343166 Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones |
| 11/20/2014 | US20140343164 Composition and method for treating neurological disease |
| 11/20/2014 | US20140343163 Composition and method for treating neurological disease |
| 11/20/2014 | US20140343162 Method for the treatment of dravet syndrome |
| 11/20/2014 | US20140343161 Method for the treatment of dravet syndrome |
| 11/20/2014 | US20140343160 Adhesive mixture for transdermal delivery of highly plasticizing drugs |
| 11/20/2014 | US20140343159 Formulation of small adrenergic agonist salt forms in organic solvents |
| 11/20/2014 | US20140343158 Compositions for topical treatment |
| 11/20/2014 | US20140343156 Methods and compositions for preventing and relieving muscle cramps and for recovery from neuromuscular irritability and fatigue following exercise |
| 11/20/2014 | US20140343154 Composition and method for treating neurological disease |
| 11/20/2014 | US20140343153 Composition and method for treating neurological disease |
| 11/20/2014 | US20140343152 Composition and method for treating neurological disease |
| 11/20/2014 | US20140343149 Method of inhibiting angiogenesis |
| 11/20/2014 | US20140343148 Prophylactic or therapeutic agent for idiopathic inflammatory myopathies |
| 11/20/2014 | US20140343147 Nutritional supplement for the enhancement of muscle performance and recovery and methods of use thereof |
| 11/20/2014 | US20140343146 Methods of Improving Bone Health and Muscle Health |
| 11/20/2014 | US20140343144 Method, pharmaceutical composition and kit for applying metformin and sodium butyrate in kras mutation cancer treatment |
| 11/20/2014 | US20140343143 Use of highly concentrated compositions of selected n-3 fatty acids for the treatment of central nervous system disturbances |